ICHAD receives $5 million NIH grant for global health research
The International Center for Child Health and Development at the Brown School has received a five-year $5 million Launching Future Leaders in Global Health training grant from the National Institutes of Health (NIH).
COVID-19 exposure-alert system that uses smartphones expands in Missouri
Washington University is expanding access to MO/Notify, a smartphone system that privately sends pop-up alerts to users in Missouri when they have spent time near someone who later tests positive for COVID-19.
Younger moms hesitant to vaccinate kids against COVID, study finds
Fathers older than age 34 were more open to having their child vaccinated against COVID-19, while younger Black and white mothers were the least open to it, finds a new survey of Medicaid recipients from the Brown School.
Child Behavioral Health in Sub-Saharan Africa
Towards Evidence Generation and Policy Development
Countries in sub-Saharan Africa have experienced considerable political and social instability. They also have the highest rates of HIV/AIDS and malaria globally, resulting in a myriad of physical and cognitive consequences for young people. The burden of mental health problems among children and adolescents in Africa is significant, and the treatment gap in mental health […]
Study highlights opportunities to improve health outcomes for non-English speakers
A survey of health-care providers reveals challenges communicating and sharing information about COVID-19 with patients whose primary language in not English.
Study examines risk factors for severe health problems in kids with COVID-19
An international study involving researchers at Washington University School of Medicine analyzed the risk factors for serious health outcomes in kids who had COVID-19. Researchers found that children up to age 18 who had tested positive for COVID-19 were at low risk for severe health problems.
U.S. drug prices are costing us more than we think
Aduhelm, the first new Alzheimer’s drug in 18 years, could easily become the best-selling drug in Medicare, despite its potential massive cost and tremendous uncertainty about whether the drug even works.
How distance from care affects cancer outcomes
In a seemingly counterintuitive finding, young adults diagnosed with central nervous system tumors might have better survival rates the farther they live from care, finds a new Brown School study.
Infectious disease initiative launches
The Brown School, the Institute for Public Health’s Center for Dissemination and Implementation and the School of Medicine’s Infectious Disease Division have launched the Infectious Disease Dissemination and Implementation Science (IDDI) Initiative.
COVID-19 boosters: An update with experts Lawrence and LeBlanc
Steven Lawrence, MD, an infectious disease specialist at the School of Medicine, and Cheri LeBlanc, MD, executive director of the Habif Health & Wellness Center on the Danforth Campus, explain how booster shots work, why the university is not requiring boosters at this time and the outlook for COVID on campus.
Older Stories